Read the order here.
Subscribe to Closing Arguments
Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.
SAN FRANCISCO — A federal court in California preliminarily approved a $10 million settlement between Bristol-Myers Squibb and end-payor plaintiffs, which claimed the company and other pharmaceutical companies engaged in anti-competitive practices that kept less expensive generic HIV drugs from being available to the class members.
Read the order here.
Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.
